Pathology and immunohistochemistry of lung cancer

E. Brambilla, S. Lantuejoul

Source: Eur Respir Mon; 2009: 44: 15–35
Journal Issue: Thoracic Malignancies
Disease area: Thoracic oncology

PDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Brambilla, S. Lantuejoul. Pathology and immunohistochemistry of lung cancer. Eur Respir Mon; 2009: 44: 15–35

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Should there be a specific management for large cell neuroendocrine carcinoma?
Source: Annual Congress 2005 - Neuroendocrine tumours of the lung
Year: 2005

Pathology of lung cancer: histology, cytology, immunohistochemistry and molecular pathology
Source: Eur Respir Mon; 2010: 48: 272–296
Year: 2010

Lung cancer: immunopathology
Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=48
Year: 2001

Immunohistochemical studies of COX-2, MMP-9, p53 and VEGF in non-small-cell lung cancer, specifically squamous cell carcinoma and adenocarcinoma
Source: Eur Respir J 2006; 28: Suppl. 50, 387s
Year: 2006

Gene expression of lung squamous cell carcinoma reflects mode of lymph node involvement
Source: Eur Respir J 2007; 30: 21-26
Year: 2007



Influence of histological subtypes of bronchioloalveolar carcinoma on prognosis and treatment
Source: Annual Congress 2006 - Prognostic factors in lung cancer
Year: 2006


Hyaluronidase, hyaluronan synthase, E-cadherin and TGF-beta profile in lung adenocarcinoma subtypes and squamous cell carcinoma of smokers/nonsmokers
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013


Improving standards in flexible bronchoscopy for lung cancer
Source: Eur Respir J 2011; 37: 895-901
Year: 2011



Lung cancer
Source: Respipedia Article
Year: 2018

Predicting activity of EGFR (epidermal growth factor receptor) inhibitors in diffuse bronchiolo-alveolar carcinoma or so-called pneumonic adenocarcinoma
Source: Annual Congress 2006 - Bronchiolo-alveolar carcinoma
Year: 2006


Therapy increases poly(ADP-ribose), p53 expression, p53-Ser392 –P, and p53-Ser2 –P levels in recurrent squamous cell lung cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 14s
Year: 2002

The expression of Ki-67, a marker of proliferative activity, in resected nonsmall cell lung cancer
Source: Eur Respir J 2001; 18: Suppl. 33, 478s
Year: 2001

Ear, nose and throat cancer and the lung
Source: ISSN=1025-448x, ISBN=1-904097-19-20, page=153
Year: 2001

Evolution of microRNA expression during human bronchial squamous carcinogenesis
Source: Eur Respir J 2009; 33: 352-359
Year: 2009



Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapy
Source: Eur Respir J 2012; 39: 1437-1442
Year: 2012



Her-2/neu expression in advanced non small cell lung carcinomas
Source: Eur Respir J 2004; 24: Suppl. 48, 77s
Year: 2004

Staging of lung cancer
Source: Eur Respir Mon; 2009: 44: 150–168
Year: 2009

Lung carcinomas with a basaloid pattern: a study of 90 cases focusing on their poor prognosis
Source: Eur Respir J 2008; 31: 854-859
Year: 2008



Significance of expression of TGF-β in pulmonary metastasis in non-small cell lung cancer tissues
Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours
Year: 2015

A tissue microarray analysis on the role of chromosome 7 multiplication regarding the EGFR expression in non-small cell lung carcinomas
Source: International Congress 2016 – Molecular targets in pulmonary disease
Year: 2016